Abstract
Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this disease and the high cost of its treatment, frequent drug resistance, different response to the drug, the possibility of using reliable methods to assess the control of seizures and side effects of antiepileptic drugs. Candidate genes encode proteins involved in pharmacokinetic processes (drug transporters, metabolizing enzymes), pharmacodynamic processes (receptors, ion channels, enzymes, regulatory proteins, secondary messengers) and drug hypersensitivity (immune factors). This article provides an overview of the literature on the influence of genetic factors on treatment in epilepsy.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference143 articles.
1. Moderne Probleme der Humangenetik;Vogel;Ergeb. Inn. Med. Kinderheilkd.,1959
2. Pharmacogenomics: The promise of personalized medicine
3. Farmakogenetyka padaczki;Klimek;Aktualn. Neurol.,2007
4. Farmakogenetyka—Nowe podejście do leczenia choroby Parkinsona;Białecka;Neurol. Neurochir. Pol.,2008
5. Farmakogenetyka leków przeciwpsychotycznych;Hauser;Psychiatria,2004
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献